Skip to main content
Erschienen in: Journal of Gastroenterology 10/2018

22.01.2018 | Original Article—Alimentary Tract

A scoring model for predicting advanced colorectal neoplasia in a screened population of asymptomatic Japanese individuals

verfasst von: Masau Sekiguchi, Yasuo Kakugawa, Minori Matsumoto, Takahisa Matsuda

Erschienen in: Journal of Gastroenterology | Ausgabe 10/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Risk stratification of screened populations could help improve colorectal cancer (CRC) screening. Use of the modified Asia-Pacific Colorectal Screening (APCS) score has been proposed in the Asia-Pacific region. This study was performed to build a new useful scoring model for CRC screening.

Methods

Data were reviewed from 5218 asymptomatic Japanese individuals who underwent their first screening colonoscopy. Multivariate logistic regression was used to investigate risk factors for advanced colorectal neoplasia (ACN), and a new scoring model for the prediction of ACN was developed based on the results. The discriminatory capability of the new model and the modified APCS score were assessed and compared. Internal validation was also performed.

Results

ACN was detected in 225 participants. An 8-point scoring model for the prediction of ACN was developed using five independent risk factors for ACN (male sex, higher age, presence of two or more first-degree relatives with CRC, body mass index of > 22.5 kg/m2, and smoking history of > 18.5 pack-years). The prevalence of ACN was 1.6% (34/2172), 5.3% (127/2419), and 10.2% (64/627) in participants with scores of < 3, ≥ 3 to < 5, and ≥ 5, respectively. The c-statistic of the scoring model was 0.70 (95% confidence interval, 0.67–0.73) in both the development and internal validation sets, and this value was higher than that of the modified APCS score [0.68 (95% confidence interval, 0.65–0.71), P = 0.03].

Conclusions

We built a new simple scoring model for prediction of ACN in a Japanese population that could stratify the screened population into low-, moderate-, and high-risk groups.
Literatur
2.
Zurück zum Zitat Schreuders EH, Ruco A, Rabeneck L, et al. Colorectal cancer screening: a global overview of existing programmes. Gut. 2015;64:1637–49.CrossRefPubMed Schreuders EH, Ruco A, Rabeneck L, et al. Colorectal cancer screening: a global overview of existing programmes. Gut. 2015;64:1637–49.CrossRefPubMed
3.
Zurück zum Zitat Saito H. Colorectal cancer screening using immunochemical faecal occult blood testing in Japan. J Med Screen. 2006;13:S6–7.PubMed Saito H. Colorectal cancer screening using immunochemical faecal occult blood testing in Japan. J Med Screen. 2006;13:S6–7.PubMed
4.
Zurück zum Zitat Hori M, Matsuda T, Shibata A, et al. Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2015;45:884–91.CrossRefPubMed Hori M, Matsuda T, Shibata A, et al. Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2015;45:884–91.CrossRefPubMed
5.
Zurück zum Zitat Betés M, Muñoz-Navas MA, Duque JM, et al. Use of colonoscopy as a primary screening test for colorectal cancer in average risk people. Am J Gastroenterol. 2003;98:2648–54.PubMed Betés M, Muñoz-Navas MA, Duque JM, et al. Use of colonoscopy as a primary screening test for colorectal cancer in average risk people. Am J Gastroenterol. 2003;98:2648–54.PubMed
6.
Zurück zum Zitat Lin OS, Kozarek RA, Schembre DB, et al. Risk stratification for colon neoplasia: screening strategies using colonoscopy and computerized tomographic colonography. Gastroenterology. 2006;131:1011–9.CrossRefPubMed Lin OS, Kozarek RA, Schembre DB, et al. Risk stratification for colon neoplasia: screening strategies using colonoscopy and computerized tomographic colonography. Gastroenterology. 2006;131:1011–9.CrossRefPubMed
7.
Zurück zum Zitat Driver JA, Gaziano JM, Gelber RP, et al. Development of a risk score for colorectal cancer in men. Am J Med. 2007;120:257–63.CrossRefPubMed Driver JA, Gaziano JM, Gelber RP, et al. Development of a risk score for colorectal cancer in men. Am J Med. 2007;120:257–63.CrossRefPubMed
8.
Zurück zum Zitat Park Y, Freedman AN, Gail MH, et al. Validation of a colorectal cancer risk prediction model among white patients age 50 years and older. J Clin Oncol. 2009;27:694–8.CrossRefPubMed Park Y, Freedman AN, Gail MH, et al. Validation of a colorectal cancer risk prediction model among white patients age 50 years and older. J Clin Oncol. 2009;27:694–8.CrossRefPubMed
9.
Zurück zum Zitat Freedman AN, Slattery ML, Ballard-Barbash R, et al. Colorectal cancer risk prediction tool for white men and women without known susceptibility. J Clin Oncol. 2009;27:686–93.CrossRefPubMed Freedman AN, Slattery ML, Ballard-Barbash R, et al. Colorectal cancer risk prediction tool for white men and women without known susceptibility. J Clin Oncol. 2009;27:686–93.CrossRefPubMed
10.
Zurück zum Zitat Wei EK, Colditz GA, Giovannucci EL, et al. Cumulative risk of colon cancer up to age 70 years by risk factor status using data from the Nurses’ Health Study. Am J Epidemiol. 2009;170:863–72.CrossRefPubMedCentralPubMed Wei EK, Colditz GA, Giovannucci EL, et al. Cumulative risk of colon cancer up to age 70 years by risk factor status using data from the Nurses’ Health Study. Am J Epidemiol. 2009;170:863–72.CrossRefPubMedCentralPubMed
11.
Zurück zum Zitat Kastrinos F, Allen JI, Stockwell DH, et al. Development and validation of a colon cancer risk assessment tool for patients undergoing colonoscopy. Am J Gastroenterol. 2009;104:1508–18.CrossRefPubMedCentralPubMed Kastrinos F, Allen JI, Stockwell DH, et al. Development and validation of a colon cancer risk assessment tool for patients undergoing colonoscopy. Am J Gastroenterol. 2009;104:1508–18.CrossRefPubMedCentralPubMed
12.
Zurück zum Zitat Ma E, Sasazuki S, Iwasaki M, Japan Public Health Center-based Prospective Study Group, et al. 10-year risk of colorectal cancer: development and validation of a prediction model in middle-aged Japanese men. Cancer Epidemiol. 2010;34:534–41.CrossRefPubMed Ma E, Sasazuki S, Iwasaki M, Japan Public Health Center-based Prospective Study Group, et al. 10-year risk of colorectal cancer: development and validation of a prediction model in middle-aged Japanese men. Cancer Epidemiol. 2010;34:534–41.CrossRefPubMed
13.
Zurück zum Zitat Yeoh KG, Ho KY, Chiu HM, Asia-Pacific Working Group on Colorectal Cancer, et al. The Asia-Pacific colorectal screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut. 2011;60:1236–41.CrossRefPubMed Yeoh KG, Ho KY, Chiu HM, Asia-Pacific Working Group on Colorectal Cancer, et al. The Asia-Pacific colorectal screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut. 2011;60:1236–41.CrossRefPubMed
14.
Zurück zum Zitat Cai QC, Yu ED, Xiao Y, et al. Derivation and validation of a prediction rule for estimating advanced colorectal neoplasm risk in average-risk Chinese. Am J Epidemiol. 2012;175:584–93.CrossRefPubMed Cai QC, Yu ED, Xiao Y, et al. Derivation and validation of a prediction rule for estimating advanced colorectal neoplasm risk in average-risk Chinese. Am J Epidemiol. 2012;175:584–93.CrossRefPubMed
15.
Zurück zum Zitat Kaminski MF, Polkowski M, Kraszewska E, et al. A score to estimate the likelihood of detecting advanced colorectal neoplasia at colonoscopy. Gut. 2014;63:1112–9.CrossRefPubMed Kaminski MF, Polkowski M, Kraszewska E, et al. A score to estimate the likelihood of detecting advanced colorectal neoplasia at colonoscopy. Gut. 2014;63:1112–9.CrossRefPubMed
16.
Zurück zum Zitat Tao S, Hoffmeister M, Brenner H. Development and validation of a scoring system to identify individuals at high risk for advanced colorectal neoplasms who should undergo colonoscopy screening. Clin Gastrointest Hepatol. 2014;12:478–85.CrossRef Tao S, Hoffmeister M, Brenner H. Development and validation of a scoring system to identify individuals at high risk for advanced colorectal neoplasms who should undergo colonoscopy screening. Clin Gastrointest Hepatol. 2014;12:478–85.CrossRef
17.
Zurück zum Zitat Kim DH, Cha JM, Shin HP, et al. Development and validation of a risk stratification-based screening model for predicting colorectal advanced neoplasia in Korea. J Clin Gastroenterol. 2015;49:41–9.CrossRefPubMed Kim DH, Cha JM, Shin HP, et al. Development and validation of a risk stratification-based screening model for predicting colorectal advanced neoplasia in Korea. J Clin Gastroenterol. 2015;49:41–9.CrossRefPubMed
18.
Zurück zum Zitat Sung JJY, Wong MC, Tsoi KK. Modified Asia-Pacific Colorectal Screening (APCS) score to stratify risk for colorectal advanced neoplasia in asymptomatic population in Asian subjects. Gastroenterology. 2014;146:S-730.CrossRef Sung JJY, Wong MC, Tsoi KK. Modified Asia-Pacific Colorectal Screening (APCS) score to stratify risk for colorectal advanced neoplasia in asymptomatic population in Asian subjects. Gastroenterology. 2014;146:S-730.CrossRef
19.
Zurück zum Zitat Wong MC, Ching JY, Ng S, et al. The discriminatory capability of existing scores to predict advanced colorectal neoplasia: a prospective colonoscopy study of 5,899 screening participants. Sci Rep. 2016;6:20080.CrossRefPubMedCentralPubMed Wong MC, Ching JY, Ng S, et al. The discriminatory capability of existing scores to predict advanced colorectal neoplasia: a prospective colonoscopy study of 5,899 screening participants. Sci Rep. 2016;6:20080.CrossRefPubMedCentralPubMed
20.
Zurück zum Zitat Sung JJY, Wong M, Lam TYT, et al. A modified colorectal screening score for prediction of advanced neoplasia: a prospective study of 5744 subjects. J Gastroenterol Hepatol. 2017;33:187–94.CrossRef Sung JJY, Wong M, Lam TYT, et al. A modified colorectal screening score for prediction of advanced neoplasia: a prospective study of 5744 subjects. J Gastroenterol Hepatol. 2017;33:187–94.CrossRef
21.
Zurück zum Zitat Sung JJ, Ng SC, Chan FK, An updated Asia Pacific Consensus Recommendations on colorectal cancer screening, et al. An updated Asia Pacific consensus recommendations on colorectal cancer screening. Gut. 2015;64:121–32.CrossRefPubMed Sung JJ, Ng SC, Chan FK, An updated Asia Pacific Consensus Recommendations on colorectal cancer screening, et al. An updated Asia Pacific consensus recommendations on colorectal cancer screening. Gut. 2015;64:121–32.CrossRefPubMed
22.
Zurück zum Zitat Hamashima C, Sobue T, Muramatsu Y, et al. Comparison of observed and expected numbers of detected cancers in the research center for cancer prevention and screening program. Jpn J Clin Oncol. 2006;36:301–8.CrossRefPubMed Hamashima C, Sobue T, Muramatsu Y, et al. Comparison of observed and expected numbers of detected cancers in the research center for cancer prevention and screening program. Jpn J Clin Oncol. 2006;36:301–8.CrossRefPubMed
23.
Zurück zum Zitat Sekiguchi M, Kakugawa Y, Terauchi T, et al. Sensitivity of 2-[18F]fluoro-2-deoxyglucose positron emission tomography for advanced colorectal neoplasms: a large-scale analysis of 7505 asymptomatic screening individuals. J Gastroenterol. 2016;51:1122–32.CrossRefPubMed Sekiguchi M, Kakugawa Y, Terauchi T, et al. Sensitivity of 2-[18F]fluoro-2-deoxyglucose positron emission tomography for advanced colorectal neoplasms: a large-scale analysis of 7505 asymptomatic screening individuals. J Gastroenterol. 2016;51:1122–32.CrossRefPubMed
24.
Zurück zum Zitat Budhathoki S, Iwasaki M, Sawada N, et al. Soy food and isoflavone intake and endometrial cancer risk: the Japan Public Health Center-based prospective study. BJOG. 2015;122:304–11.CrossRefPubMed Budhathoki S, Iwasaki M, Sawada N, et al. Soy food and isoflavone intake and endometrial cancer risk: the Japan Public Health Center-based prospective study. BJOG. 2015;122:304–11.CrossRefPubMed
25.
Zurück zum Zitat Participants in the Paris Workshop. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc. 2003;58(Suppl):S3–43.CrossRef Participants in the Paris Workshop. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc. 2003;58(Suppl):S3–43.CrossRef
26.
Zurück zum Zitat Edge SB, Byrd DR, Compton CC, et al., editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2010. Edge SB, Byrd DR, Compton CC, et al., editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.
27.
Zurück zum Zitat Hamiliton SR, Bosman FT, Boffetta P, et al. Carcinoma of the colon and rectum. In: Bosman FT, Carneiro F, Hruban RH, et al., editors. WHO classification of tumors of the digestive system. 4th ed. Lyon: IARC; 2010. p. 134–46. Hamiliton SR, Bosman FT, Boffetta P, et al. Carcinoma of the colon and rectum. In: Bosman FT, Carneiro F, Hruban RH, et al., editors. WHO classification of tumors of the digestive system. 4th ed. Lyon: IARC; 2010. p. 134–46.
28.
Zurück zum Zitat Winawer SJ, Zauber AG. The advanced adenoma as the primary target of screening. Gastrointest Endosc Clin N Am. 2002;12:1–9.CrossRefPubMed Winawer SJ, Zauber AG. The advanced adenoma as the primary target of screening. Gastrointest Endosc Clin N Am. 2002;12:1–9.CrossRefPubMed
29.
Zurück zum Zitat Schlemper RJ, Itabashi M, Kato Y, et al. Differences in the diagnostic criteria used by Japanese and Western pathologists to diagnose colorectal carcinoma. Cancer. 1998;82:60–9.CrossRefPubMed Schlemper RJ, Itabashi M, Kato Y, et al. Differences in the diagnostic criteria used by Japanese and Western pathologists to diagnose colorectal carcinoma. Cancer. 1998;82:60–9.CrossRefPubMed
30.
Zurück zum Zitat Moons KG, Kengne AP, Woodward M, et al. Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker. Heart. 2012;98:683–90.CrossRefPubMed Moons KG, Kengne AP, Woodward M, et al. Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker. Heart. 2012;98:683–90.CrossRefPubMed
31.
Zurück zum Zitat Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29–36.CrossRefPubMed Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29–36.CrossRefPubMed
32.
Zurück zum Zitat Regula J, Rupinski M, Kraszewska E, et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med. 2006;355:1863–72.CrossRefPubMed Regula J, Rupinski M, Kraszewska E, et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med. 2006;355:1863–72.CrossRefPubMed
33.
Zurück zum Zitat Strul H, Kariv R, Leshno M, et al. The prevalence rate and anatomic location of colorectal adenoma and cancer detected by colonoscopy in average-risk individuals aged 40–80 years. Am J Gastroenterol. 2006;101:255–62.CrossRefPubMed Strul H, Kariv R, Leshno M, et al. The prevalence rate and anatomic location of colorectal adenoma and cancer detected by colonoscopy in average-risk individuals aged 40–80 years. Am J Gastroenterol. 2006;101:255–62.CrossRefPubMed
34.
Zurück zum Zitat Pendergrass CJ, Edelstein DL, Hylind LM, et al. Occurrence of colorectal adenomas in younger adults: an epidemiologic necropsy study. Clin Gastroenterol Hepatol. 2008;6:1011–5.CrossRefPubMedCentralPubMed Pendergrass CJ, Edelstein DL, Hylind LM, et al. Occurrence of colorectal adenomas in younger adults: an epidemiologic necropsy study. Clin Gastroenterol Hepatol. 2008;6:1011–5.CrossRefPubMedCentralPubMed
35.
Zurück zum Zitat Boursi B, Halak A, Umansky M, et al. Colonoscopic screening of an average-risk population for colorectal neoplasia. Endoscopy. 2009;41:516–21.CrossRefPubMed Boursi B, Halak A, Umansky M, et al. Colonoscopic screening of an average-risk population for colorectal neoplasia. Endoscopy. 2009;41:516–21.CrossRefPubMed
36.
Zurück zum Zitat Heitman SJ, Ronksley PE, Hilsden RJ, et al. Prevalence of adenomas and colorectal cancer in average risk individuals: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2009;7:1272–8.CrossRefPubMed Heitman SJ, Ronksley PE, Hilsden RJ, et al. Prevalence of adenomas and colorectal cancer in average risk individuals: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2009;7:1272–8.CrossRefPubMed
37.
Zurück zum Zitat Byeon JS, Yang SK, Kim TI, Asia Pacific Working Group for Colorectal Cancer, et al. Colorectal neoplasm in asymptomatic Asians: a prospective multinational multicenter colonoscopy survey. Gastrointest Endosc. 2007;65:1015–22.CrossRefPubMed Byeon JS, Yang SK, Kim TI, Asia Pacific Working Group for Colorectal Cancer, et al. Colorectal neoplasm in asymptomatic Asians: a prospective multinational multicenter colonoscopy survey. Gastrointest Endosc. 2007;65:1015–22.CrossRefPubMed
38.
Zurück zum Zitat Hassan C, Pickhardt PJ, Kim DH, et al. Systematic review: distribution of advanced neoplasia according to polyp size at screening colonoscopy. Aliment Pharmacol Ther. 2010;31:210–7.PubMed Hassan C, Pickhardt PJ, Kim DH, et al. Systematic review: distribution of advanced neoplasia according to polyp size at screening colonoscopy. Aliment Pharmacol Ther. 2010;31:210–7.PubMed
39.
Zurück zum Zitat Corley DA, Jensen CD, Marks AR, et al. Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs. Clin Gastroenterol Hepatol. 2013;11:172–80.CrossRefPubMed Corley DA, Jensen CD, Marks AR, et al. Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs. Clin Gastroenterol Hepatol. 2013;11:172–80.CrossRefPubMed
40.
Zurück zum Zitat Rex DK, Helbig CC. High yields of small and flat adenomas with high-definition colonoscopes using either white light or narrow band imaging. Gastroenterology. 2007;133:42–7.CrossRefPubMed Rex DK, Helbig CC. High yields of small and flat adenomas with high-definition colonoscopes using either white light or narrow band imaging. Gastroenterology. 2007;133:42–7.CrossRefPubMed
41.
Zurück zum Zitat Chiu HM, Ching JY, Wu KC, et al. A risk-scoring system combined with a fecal immunochemical test is effective in screening high-risk subjects for early colonoscopy to detect advanced colorectal neoplasms. Gastroenterology. 2016;150:617–25.CrossRefPubMed Chiu HM, Ching JY, Wu KC, et al. A risk-scoring system combined with a fecal immunochemical test is effective in screening high-risk subjects for early colonoscopy to detect advanced colorectal neoplasms. Gastroenterology. 2016;150:617–25.CrossRefPubMed
42.
Zurück zum Zitat Butterworth AS, Higgins JP, Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer. 2006;42:216–27.CrossRefPubMed Butterworth AS, Higgins JP, Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer. 2006;42:216–27.CrossRefPubMed
43.
Zurück zum Zitat Schoen RE, Razzak A, Yu KJ, et al. Incidence and mortality of colorectal cancer in individuals with a family history of colorectal cancer. Gastroenterology. 2015;149:1438–45.CrossRefPubMed Schoen RE, Razzak A, Yu KJ, et al. Incidence and mortality of colorectal cancer in individuals with a family history of colorectal cancer. Gastroenterology. 2015;149:1438–45.CrossRefPubMed
44.
Zurück zum Zitat Quintero E, Carrillo M, Leoz ML, Oncology Group of the Asociación Española de Gastroenterología, et al. Risk of advanced neoplasia in first-degree relatives with colorectal cancer: a Large Multicenter Cross-Sectional Study. PLoS Med. 2016;13:e1002008.CrossRefPubMedCentralPubMed Quintero E, Carrillo M, Leoz ML, Oncology Group of the Asociación Española de Gastroenterología, et al. Risk of advanced neoplasia in first-degree relatives with colorectal cancer: a Large Multicenter Cross-Sectional Study. PLoS Med. 2016;13:e1002008.CrossRefPubMedCentralPubMed
45.
Zurück zum Zitat Rex DK, Schoenfeld PS, Cohen J, et al. Quality indicators for colonoscopy. Gastrointest Endosc. 2015;81:31–53.CrossRefPubMed Rex DK, Schoenfeld PS, Cohen J, et al. Quality indicators for colonoscopy. Gastrointest Endosc. 2015;81:31–53.CrossRefPubMed
46.
Zurück zum Zitat Moons KG, Kengne AP, Grobbee DE, et al. Risk prediction models: II. External validation, model updating, and impact assessment. Heart. 2012;98:691–8.CrossRefPubMed Moons KG, Kengne AP, Grobbee DE, et al. Risk prediction models: II. External validation, model updating, and impact assessment. Heart. 2012;98:691–8.CrossRefPubMed
Metadaten
Titel
A scoring model for predicting advanced colorectal neoplasia in a screened population of asymptomatic Japanese individuals
verfasst von
Masau Sekiguchi
Yasuo Kakugawa
Minori Matsumoto
Takahisa Matsuda
Publikationsdatum
22.01.2018
Verlag
Springer Japan
Erschienen in
Journal of Gastroenterology / Ausgabe 10/2018
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-018-1433-7

Weitere Artikel der Ausgabe 10/2018

Journal of Gastroenterology 10/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.